Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Disc Medicine, Inc.

Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

OrbiMed

Access Biotechnology

Bain Capital Life Sciences

Novo Holdings

Janus Henderson Investors

Rock Springs Capital

5AM Ventures

Arix Bioscience

Atlas Venture

Nantahala Capital Management

Disc Medicine

	Dec '20	Dec '21	Dec '22	Dec '23
revenue
cost of revenue	322K -	192K 40.37%	300K 56.25%
gross profit	-322K -	-192K 40.37%	-300K 56.25%
selling and marketing expenses
general and administrative expenses	5.87M -	5.76M 1.82%	14.04M 143.59%
selling general and administrative expenses	5.87M -	5.76M 1.82%	14.04M 143.59%	21.86M 55.73%
research and development expenses	28.17M -	25.17M 10.65%	33.44M 32.84%	69.26M 107.15%
other expenses		-724K -	648K 189.50%
cost and expenses	34.04M -	30.93M 9.13%	47.48M 53.48%	91.13M 91.94%
operating expenses	34.04M -	30.93M 9.13%	47.48M 53.48%	91.13M 91.94%
interest expense	6.83M -	2.16M 68.39%	-737K 134.15%
ebitda	-33.68M -	-25.85M 23.25%	-47.48M 83.65%	-91.13M 91.94%
operating income	-34.04M -	-30.93M 9.13%	-47.48M 53.48%	-91.13M 91.94%
depreciation and amortization	359K -	5.08M 1,315.60%	89K 98.25%
total other income expenses net	-6.80M -	-5.04M 25.91%	648K 112.87%	14.79M 2,183.18%
income before tax	-40.84M -	-35.97M 11.92%	-46.83M 30.19%	-76.33M 63.00%
income tax expense	6.83M -	5.04M 26.22%	-737K 114.63%	99K 113.43%
net income	-47.66M -	-41.01M 13.97%	-46.09M 12.40%	-76.43M 65.83%
weighted average shs out	1.51M -	878.41K 41.89%	1.04M 18.34%	22.32M 2,046.81%
weighted average shs out dil	1.51M -	878.41K 41.89%	1.04M 18.34%	22.32M 2,046.81%
eps	-31.53 -	-46.68 48.05%	-44.34 5.01%	-3.42 92.29%
epsdiluted	-31.53 -	-46.68 48.05%	-44.34 5.01%	-3.42 92.29%

NASDAQ:IRON

Disc Medicine, Inc.

Last Close

43.92

26/07 20:00

Market Cap

1.36B

Beta: -

Volume Today

207.34K

Avg: 239.90K

PE Ratio

−23.00

PFCF: −24.49

Preview